-PDF Download- Advanced Breast Cancer EBOOK

100 Questions & Answers About Advanced & Metastatic Breast Cancer

Author: Lillie D. Shockney

Publisher: Jones & Bartlett Publishers

Published: 2011-06

Total Pages: 158

ISBN-13: 1449643361

EMPOWER YOURSELF! Whether you're a newly diagnosed patient, survivor, or loved one of someone suffering from advanced breast cancer, 100 Questions & Answers About Advanced and Metastatic Breast Cancer, Second Edition offers essential and practical guidance. Providing both doctor and patient perspectives, this updated and revised edition offers authoritative answers to the most commonly asked questions about advanced and metastatic breast cancer including diagnosis, treatment, post-treatment quality of life, alternative medicine, targeted therapy, and coping strategies. Written by experts from Johns Hopkins University and Medical Center, this new edition is an invaluable resource for anyone coping with the physical and emotional turmoil of this disease.

Advanced Breast Cancer

Author: Musa Mayer

Publisher: Patient-Centered Guides

Published: 1998

Total Pages: 548

ISBN-13: 9781565925229

DOWNLOAD EBOOK →

This book discusses the realities of metastatic breast cancer. All aspects of the disease are covered: gathering information; coping with recurrent disease; making treatment choices; communicating with health professionals; and discussing end of life issues. Inspirational stories from those who have been there are also featured.

Breast Cancer in Young Women

Author: Oreste Gentilini

Publisher: Springer Nature

Published: 2020-02-07

Total Pages: 218

ISBN-13: 3030247627

DOWNLOAD EBOOK →

This contributed book covers all aspects concerning the clinical scenario of breast cancer in young women, providing physicians with the latest information on the topic. Young women are a special subset of patients whose care requires dedicated expertise. The book, written and edited by internationally recognized experts who have been directly involved in the international consensus guidelines for breast cancer in young women, pays particular attention to how the disease and its planned treatment can be effectively communicated to young patients. Highly informative and carefully structured, it provides both theoretical and practice-oriented insight for practitioners and professionals involved in the different phases of treatment, from diagnosis to intervention, to follow-up – without neglecting the important role played by prevention.

The Insider's Guide to Metastatic Breast Cancer

Author: Anne Loeser

Publisher: Independently Published

Published: 2019-02-07

Total Pages: 357

ISBN-13: 9781795860604

DOWNLOAD EBOOK →

The author, herself a metastatic breast cancer patient, created this book to help patients and their loved ones cope with a complex and difficult disease. The Insider's Guide to Metastatic Breast Cancer provides information about approved therapies in the U.S., Canada, Europe, and Australia, as well as scientific studies, cutting edge research, clinical trials, and palliative care.The adage that "knowledge is power" is particularly compelling when dealing with issues affecting survival and quality of life. Consequently, this fact-based handbook is a must-read for every patient contending with treatment decisions and side effects.

Breast Cancer Metastasis and Drug Resistance

Author: Aamir Ahmad

Publisher: Springer Nature

Published: 2019-08-27

Total Pages: 427

ISBN-13: 3030203018

DOWNLOAD EBOOK →

Resistance to therapies, both targeted and systemic, and metastases to distant organs are the underlying causes of breast cancer-associated mortality. The second edition of Breast Cancer Metastasis and Drug Resistance brings together some of the leading experts to comprehensively understand breast cancer: the factors that make it lethal, and current research and clinical progress. This volume covers the following core topics: basic understanding of breast cancer (statistics, epidemiology, racial disparity and heterogeneity), metastasis and drug resistance (bone metastasis, trastuzumab resistance, tamoxifen resistance and novel therapeutic targets, including non-coding RNAs, inflammatory cytokines, cancer stem cells, ubiquitin ligases, tumor microenvironment and signaling pathways such as TRAIL, JAK-STAT and mTOR) and recent developments in the field (epigenetic regulation, microRNAs-mediated regulation, novel therapies and the clinically relevant 3D models). Experts also discuss the advances in laboratory research along with their translational and clinical implications with an overarching goal to improve the diagnosis and prognosis, particularly that of breast cancer patients with advanced disease.

Diagnosing and Treating Adult Cancers and Associated Impairments

Author: National Academies Of Sciences Engineeri

Publisher: National Academies Press

Published: 2021-11-10

Total Pages:

ISBN-13: 9780309684002

DOWNLOAD EBOOK →

Cancer is the second leading cause of death among adults in the United States after heart disease. However, improvements in cancer treatment and earlier detection are leading to growing numbers of cancer survivors. As the number of cancer survivors grows, there is increased interest in how cancer and its treatments may affect a person's ability to work, whether the person has maintained employment throughout the treatment or is returning to work at a previous, current, or new place of employment. Cancer-related impairments and resulting functional limitations may or may not lead to disability as defined by the U.S. Social Security Administration (SSA), however, adults surviving cancer who are unable to work because of cancer-related impairments and functional limitations may apply for disability benefits from SSA. At the request of SSA, Diagnosing and Treating Adult Cancers and Associated Impairments provides background information on breast cancer, lung cancer, and selected other cancers to assist SSA in its review of the listing of impairments for disability assessments. This report addresses several specific topics, including determining the latest standards of care as well as new technologies for understanding disease processes, treatment modalities, and the effect of cancer on a person's health and functioning, in order to inform SSA's evaluation of disability claims for adults with cancer.

Targeted Therapies for Lung Cancer

Author: Ravi Salgia

Publisher: Springer

Published: 2019-06-26

Total Pages: 238

ISBN-13: 3030178323

DOWNLOAD EBOOK →

This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patient’s genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance.

Targeted Therapies in Breast Cancer

Author: Gw Sledge

Publisher: Clinical Pub

Published: 2012-06

Total Pages: 0

ISBN-13: 9781846920660

DOWNLOAD EBOOK →

This new volume updates the reader on selected areas of targeted therapy in breast cancer, with special emphasis on chemoprevention strategies, drug resistance, biomarkers, combination chemotherapy, angiogenesis inhibition and pharmacogenomics in the context of clinical efficacy. This selected review of targeted therapies will guide the reader on effective treatment as part of an integrated programme of patient management.

100 Questions & Answers about Metastatic Breast Cancer

Author: Lillie D. Shockney

Publisher: Jones & Bartlett Learning

Published: 2021-03-15

Total Pages: 215

ISBN-13: 1284220710

DOWNLOAD EBOOK →

The American Cancer Society estimates over 275,000 new breast cancer diagnoses in American women for 2020. No one with breast cancer needs to be alone in their fight against this disease. That's where this book and the authoritative information within can help. This unique book provides both doctor and patient perspectives and offers answers to the most asked questions by patients and their loved ones. What is metastatic breast cancer? How will my oncologist decide how to treat my metastatic breast cancer? What is targeted therapy? Along with the answers to these and other questions, this book provides information on diagnosis, treatment, living with metastatic breast cancer, hormonal therapy, coping strategies, and more.

Precision Medicine in Oncology

Author: Angela Re

Publisher: Frontiers Media SA

Published: 2019-01-21

Total Pages: 163

ISBN-13: 2889457052

DOWNLOAD EBOOK →

The emerging precision medicine approach aims to tailor disease prevention and treatment to each patient on the basis of individual variability, environmental factors and lifestyle. Fundamental achievements in the last few decades have converged to offer nowadays the compelling opportunity to move towards this innovative approach: i) unprecedented improvements in disease modeling in silico, in vitro and in vivo; ii) acquisition of a wide range of biomedical information combined with the development of computational toolsets for flexible and integrative analyses of multi-assay datasets. Our deeper understanding of oncogenic mechanisms has finally begun to have a crucial impact on clinical decisions at several steps, from cancer prevention and diagnosis to therapeutic intervention. However, precision oncology still encounters several unresolved hurdles including tumour heterogeneity and recurrence as well as unexplained drug resistance and lack of effective ways to monitor response to therapeutic treatments. Notably, limitations in biomedical research regulation and governance represent additional debatable issues that need careful consideration.